ストックスクリーナーアプリを入手
7.54
1.44%
-0.11
前日終値:
$7.65
開ける：
$7.67
24時間の取引高:
11,074
Relative Volume:
0.04
時価総額：
$504.33M
収益：
$555.06M
当期純損益:
$-39.48M
株価収益率:
-12.57
EPS:
-0.6
ネットキャッシュフロー:
$29.05M
1週間 パフォーマンス:
+1.35%
1か月 パフォーマンス:
+6.35%
6か月 パフォーマンス:
+10.56%
1年 パフォーマンス:
-21.05%
1日の値動き範囲:
$7.51
$7.70
1週間の範囲:
$7.14
$7.78
52週間の値動き範囲:
$5.81
$11.25
Bioventus Inc Stock (BVS) Company Profile
名前
Bioventus Inc
セクター
電話
(919) 474-6700
住所
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
7.53 | 512.37M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
126.91 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.45 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
364.76 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.58 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.63 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-17 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-12-07 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | アップグレード | Craig Hallum | Hold → Buy |
| 2022-11-22 | ダウングレード | Craig Hallum | Buy → Hold |
| 2022-11-09 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 開始されました | Craig Hallum | Buy |
| 2021-11-15 | 再開されました | Morgan Stanley | Overweight |
| 2021-11-10 | 再開されました | JP Morgan | Overweight |
| 2021-07-01 | ダウングレード | Goldman | Buy → Neutral |
| 2021-03-08 | 開始されました | Canaccord Genuity | Buy |
| 2021-03-08 | 開始されました | Goldman | Buy |
| 2021-03-08 | 開始されました | JP Morgan | Overweight |
| 2021-03-08 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Bioventus Inc (BVS) 最新ニュース
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
(BVS) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business - MSN
Will Bioventus Inc stock deliver consistent dividends2025 Earnings Impact & Growth Focused Investment Plans - moha.gov.vn
Bioventus (NYSE:BVS) Trading Down 1.1%Time to Sell? - MarketBeat
Why (BVS) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Aug Analyst Calls: Why Bioventus Inc stock could outperform in 2025Gap Up & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will Bioventus Inc. stock deliver consistent dividends2025 Market Outlook & Verified High Yield Trade Plans - Bölüm Sonu Canavarı
Why Bioventus Inc. stock is favored by top institutionsJuly 2025 Trade Ideas & Capital Efficiency Focused Strategies - Улправда
What Wall Street predicts for Bioventus Inc. stock priceJuly 2025 Weekly Recap & Weekly Watchlist of Top Performers - Улправда
Will Bioventus Inc. stock benefit from automationJuly 2025 Institutional & Reliable Price Breakout Alerts - DonanımHaber
Will Bioventus Inc. stock rally after Fed decisionsJuly 2025 Opening Moves & Target Return Focused Stock Picks - Улправда
Is Bioventus Inc. stock resilient to inflation2025 Market WrapUp & Community Consensus Picks - Улправда
BVS (Bioventus) Purchase Of Investment : $0.0 Mil (TTM As of Sep. 2025) - GuruFocus
Bioventus (BVS) Receives a Buy from Canaccord Genuity - The Globe and Mail
Bioventus Earnings Notes - Trefis
(BVS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Bioventus Reports Strong Q3 2025 Financial Performance - MSN
Bioventus (NYSE:BVS) Director Sells $75,700.00 in Stock - MarketBeat
Bioventus Director Guy P Nohra Sells 10,000 Shares - TradingView — Track All Markets
Dir Nohra Sells 10,000 ($75.7K) Of Bioventus Inc [BVS] - TradingView — Track All Markets
Divisadero Street Capital Management LP Decreases Stock Position in Bioventus Inc. $BVS - MarketBeat
Geode Capital Management LLC Has $6.98 Million Stake in Bioventus Inc. $BVS - Defense World
American Century Companies Inc. Grows Stock Holdings in Bioventus Inc. $BVS - Defense World
Buy Signal: Why Bioventus Inc stock is favored by top institutionsQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - moha.gov.vn
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha
Dir Nohra Files To Sell 10,000 Of Bioventus Inc [BVS] - TradingView
Is It Too Late To Consider Buying Bioventus Inc. (NASDAQ:BVS)? - Yahoo Finance
Will Bioventus Inc. stock reach Wall Street targetsTrade Exit Summary & Real-Time Market Sentiment Reports - Newser
Will Bioventus Inc. stock see insider buyingWeekly Stock Report & Short-Term High Return Ideas - Newser
(BVS) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Bioventus: A New Start (NASDAQ:BVS) - Seeking Alpha
How Bioventus Inc. stock performs in weak economy2025 Top Gainers & Reliable Volume Spike Alerts - Newser
Bioventus (NASDAQ:BVS) Seems To Use Debt Quite Sensibly - 富途牛牛
Bioventus (NYSE:BVS) Trading Down 3.9%Here's What Happened - MarketBeat
Bioventus, Inc. Reports Strong Q3 Earnings Growth - MSN
Segall Bryant & Hamill LLC Purchases 232,302 Shares of Bioventus Inc. $BVS - MarketBeat
[Form 3] Bioventus Inc. Initial Statement of Beneficial Ownership - Stock Titan
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
Bioventus (Nasdaq: BVS) to present at Piper Sandler 37th Healthcare Conference webcast - Stock Titan
Bioventus (NYSE:BVS) Shares Up 9.9%Time to Buy? - MarketBeat
Bioventus Appoints Ajay Dhankhar as New Director - MSN
Is Bioventus Inc. stock affected by interest rate hikesRisk Management & Weekly Chart Analysis and Guides - newser.com
Why Bioventus Inc. stock appeals to analystsJuly 2025 Decliners & Weekly Market Pulse Updates - newser.com
Is Bioventus Inc. stock attractive for income investorsMarket Trend Review & Risk Adjusted Buy and Sell Alerts - newser.com
Bioventus Inc. stock prediction for this weekDollar Strength & High Conviction Investment Ideas - newser.com
Bioventus Inc (BVS) 財務データ
収益
当期純利益
現金流量
EPS
0.62%
0.98%
大文字化:
|
ボリューム (24 時間):